UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor
- PMID: 20497197
- PMCID: PMC6493780
- DOI: 10.1111/j.1755-5949.2009.00107.x
UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor
Abstract
Nociceptin/orphanin FQ (N/OFQ) controls several biological functions via selective activation of the N/OFQ peptide receptor (NOP). [(pF)Phe(4) Aib(7) Arg(14) Lys(15) ]N/OFQ-NH(2) (UFP-112) is an NOP receptor ligand designed using a combination of several chemical modifications in the same peptide sequence that increase NOP receptor affinity/potency and/or reduce susceptibility to enzymatic degradation. In the present review article, we summarize data from the literature and present original findings on the in vitro and in vivo pharmacological features of UFP-112. Moreover, important biological actions and possible therapeutic indications of NOP receptor agonists are discussed based on the results obtained with UFP-112 and compared with other peptide and nonpeptide NOP receptor ligands.
© 2010 Blackwell Publishing Ltd.
Conflict of interest statement
The authors have no conflict of interest.
Figures
References
-
- Jacoby E, Bouhelal R, Gerspacher M, Seuwen K. The 7 TM G‐protein‐coupled receptor target family. Chem Med Chem 2006;1:761–782. - PubMed
-
- Lambert DG. The nociceptin/orphanin FQ receptor: A target with broad therapeutic potential. Nat Rev Drug Discov 2008;7:694–710. - PubMed
-
- Evans CJ, Keith DE, Jr ., Morrison H, Magendzo K, Edwards RH. Cloning of a delta opioid receptor by functional expression. Science 1992;258:1952–1955. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
